It is very important to consider that the BMI in patients with left-side hemiplegia was greater than in patients with right-side hemiplegia. However, obesity (BMI greater than 30) leads to significant reductions in spirometric parameters, a fact not observed http://www.selleckchem.com/B-Raf.html in the sample with left-side hemiplegia. Given the physiologic position of the diaphragm domes and the entire affected musculature on the paralyzed side, right-side hemiplegia suggests greater impairment of the respiratory system when compared to left-side hemiplegia. However, we observed that the respiratory system is able to compensate for small changes in diaphragmatic mobility in order

to maintain ventilation, evidenced by normal vital capacity data. Low PEF and FEF25–75% Baf-A1 reflects trunk muscle dysfunction and, regardless of compromised cupulae, hemiplegic patients suffer from reduced cough effectiveness. This has a direct effect on mucociliary clearance, predisposing these individuals to respiratory tract infections, as well as increased morbidity, mortality and hospitalizations. “
“Several studies have provided preclinical data regarding the therapeutic benefits of mesenchymal stem cells (MSCs) in sepsis (Gonzalez-Rey et al., 2009, Nemeth et al., 2009 and Mei et al., 2010). The administration of MSCs 24 h before and 1 h

after surgery has been evaluated in experimental sepsis induced by cecal ligation and puncture (CLP) (Nemeth et al., 2009), resulting in decreased pro-inflammatory cytokine release, as well as peritoneal, renal, and liver vascular permeability. A further report showed that treatment with human or murine adipose-derived MSCs improved survival and organ dysfunction in a sepsis check details model (Gonzalez-Rey et al., 2009). A recently published study (Mei

et al., 2010) has also demonstrated that intravenous MSC therapy was effective at reducing systemic and pulmonary inflammation as well as enhancing bacterial clearance, resulting in lower mortality. So far, however, no study in experimental polymicrobial sepsis has elucidated whether the early beneficial effects of cell therapy observed on lung and distal organs were preserved late in the course of injury. In the current study, we employed bone marrow-derived mononuclear cells (BMDMCs), which are safely administered on the day of harvesting, to test the hypothesis that cell therapy at an early phase of CLP-induced sepsis may have lasting effects on: (1) respiratory mechanics, (2) lung histology, (3) the structural remodelling of lung parenchyma, (4) lung, kidney and liver cell apoptosis, and (5) pro- and anti-inflammatory cytokines and growth factors. These parameters were studied early (one day) and late (seven days) after sepsis induction. This study was approved by the Ethics Committee of the Health Sciences Centre, Federal University of Rio de Janeiro.